Suchergebnisse - "McLellan, Susan"

PubPharm (11)

1

Hydrogen Sulfide Ameliorates SARS-CoV-2–Associated Lung Endothelial Barrier Disruption

enthalten in: Preprints.org | 2023

von Escaffre, O. | Szaniszlo, P. | Törő, G. | +9

2

Hydrogen Sulfide Ameliorates SARS-CoV-2-Associated Lung Endothelial Barrier Disruption

enthalten in: Biomedicines | 2023

von Escaffre, O. | Szaniszlo, P. | Törő, G. | +9

3

Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients

enthalten in: Viruses | 2022

von Plante, J. | Machado, R. | Mitchell, B. | +15

4

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4) : a randomised, double-blind, double placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Wolfe, C. | Tomashek, K. | Patterson, T. | +162

CommentIn: Ann Intern Med. 2022 Oct;175(10):JC115. - PMID 36191322

5

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients : Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2

enthalten in: Open forum infectious diseases | 2022

von Fintzi, J. | Bonnett, T. | Tebas, P. | +16

6

Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1 : Implications for Critical Care Resource Utilization

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Fintzi, J. | Bonnett, T. | Sweeney, D. | +7

7

Synthetic proteins for COVID-19 diagnostics

enthalten in: Peptides | 2021

von Schein, C. | Levine, C. | McLellan, S. | +5

8

Synthetic protein antigens for COVID-19 diagnostics

enthalten in: bioRxiv.org | 2021

von Schein, C. | Levine, C. | McLellan, S. | +5

9

Remdesivir for the Treatment of Covid-19 - Final Report

enthalten in: The New England journal of medicine | 2020

von Beigel, J. | Tomashek, K. | Dodd, L. | +138

CommentIn: N Engl J Med. 2020 Nov 5;383(19):1886-1887. - PMID 32459913

10

COVID-19-We urgently need to start developing an exit strategy

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von Petersen, E. | Wasserman, S. | Lee, S. | +6